Acute Myeloid Leukemia (AML) Latest Advances
Find the Latest Research About Acute Myeloid Leukemia (AML)
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87187 publications
Correction to: Targeting of acute myeloid leukemia by five-gene engineered T cells expressing transgenic T-cell receptor specific to WT1, chimeric antigenic receptor specific to GM-CSF receptor, bispecific T-cell engager specific to CD33, and tEGFR suicide gene system.
Journal: Immunotherapy advances
Published: October 31, 2026
Blast morphological abnormalities in de novo acute myeloid leukemia (excluding acute promyelocytic leukemia): associations with genetic alterations and diagnostic value of pseudo-Chediak-Higashi inclusions for the t(8;21) translocation
Journal: Annales de biologie clinique
Published: October 31, 2026
Acute promyelocytic leukemia with clonal hematopoiesis: a case study of APL in complete molecular remission transitioning to MDS/MPN and its clinical implications.
Journal: Leukemia & lymphoma
Published: October 30, 2026
Single-Cell RNA sequencing analysis of cellular heterogeneity and microenvironment-driven signaling networks in acute myeloid leukemia.
Journal: Leukemia & lymphoma
Published: October 30, 2026
Intravital Imaging of Early AML Expansion in the Mouse Calvarial Bone Marrow.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 30, 2026
Targeting menin dependency in acute leukemias: the role of revumenib in NPM1-mutated and KMT2A/NUP98-rearranged disease.
Journal: Future oncology (London, England)
Published: October 29, 2026
Time burden and treatment patterns of patients with newly diagnosed acute myeloid leukemia receiving parenteral hypomethylating agents in combination with venetoclax.
Journal: Leukemia & lymphoma
Published: October 29, 2026
Patients' preferences for accepting risks and uncertainty in AML treatments within European public health care systems: a cross-sectional study in Finland, Italy, and Germany.
Journal: Leukemia & lymphoma
Published: October 29, 2026
Targeting leukemia-specific transcriptional hubs in AML: menin inhibition and beyond
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 28, 2026
Metronomic per oral decitabine-cedazuridine plus venetoclax in acute myeloid leukemia.
Journal: Leukemia & lymphoma
Published: October 28, 2026
Measurable residual disease in acute myeloid leukemia: clinical significance and emerging roles in personalized therapy
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 28, 2026
Features of the prevalence of acute leukemia and their clinical manifestations in the oral cavity in elderly and senile individuals.
Journal: Advances in gerontology = Uspekhi gerontologii
Published: October 27, 2026
Last Updated: 11/08/2026